BioWorld

July 17, 2003

View Archived Issues

AVI BioPharma Getting Antisense, Cash Through eXegenics Purchase

Read More

Bacillus anthracis Fires Arsenal Of Toxic Factors At Immune System, Leaving Dendritic Cells In Tatters

Read More

Genzyme Earnings Driven By Better-Than-Expected Sales

Read More

Genetronics Secures Two-Tranche Financing Of $15.7M

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

'Integrated' Lexicon Genetics Could Raise $70M In Offering

Pursuant to last November's shelf registration, Lexicon Genetics Inc. said it plans to sell 10 million shares of stock, which, based on Tuesday's closing price of $7, would raise $70 million. (BioWorld Today) Read More